In Vivo Analysis of Extract of Leaves of Mistletoe as a Benalu Duku: Clinical Chemical Value Associated with Histopathology, Liver, Kidneys, and Lethal Dose Determinate

• Published in: Veterinary medicine international Vol. 2022; pp. 1182866 - 11
• Main Authors: Lazuardi, Mochamad, Chien, Chi-Hsien, Jie-Long, He, Eka, Pramyrtha Hestianah
• Format: Journal Article
• Language: English
• Published: United States Hindawi 12.12.2022; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Alanine transaminase; Animals; Aspartate; Aspartate aminotransferase; Automation; Chemistry; Comparative analysis; Creatinine; Degeneration; Drug dosages; Histochemistry; Hormones, Sex; Kidneys; Lethal dose; Liver; Medicine; Medicine, Botanic; Medicine, Herbal; NMR; Nuclear magnetic resonance; Progesterone; Reagents; Steroids; Thermogravimetric analysis; Veterinary medicine; Indonesia; United States > US
• ISSN: 2090-8113; 2042-0048; 2042-0048
• DOI: 10.1155/2022/1182866

The active compounds from the leaves of Dendrophthoe pentandra L. Miq., also known as, Benalu Duku (in Indonesia), are known to contain progesterone-like compounds (PLCs). This study aims to determine the effect of giving a single dose of PLCs on liver and kidney function in rats and the dose limit that causes the death of experimental animals. The PLCs were analyzed for chemical and physical characterization and compared to a pure standard of progesterone using HPLC, IR spectrometry, thermogravimetry, and NMR. The research was carried out in two sections. In section one, thirty-five healthy adult male rats were divided into six experimental groups and a control group of five rats each. The groups received, respectively, 50 to 75 mg/kg of PLCs (i.p.). The control group was given a 0.5 mL Aqua Pro injection. Alanine aminotransferase, aspartate aminotransferase, creatinine, and blood urea nitrogen were assessed using the clinical chemistry of blood serum analysis. Cell disruptions were analyzed to determine the degeneration effects of PLCs on the liver and kidney in the experimental and control groups. In section two, thirty healthy adult male rats were divided into 6 groups, each group of 5 rats, and injected with PLCs at a dose of 0.9–2.1 g/kg BW, followed by a lethal dose test. The control groups were available for 5 individual rats at 0 g/kg BW of PLCs. Our findings indicated that PLCs have a similarity chemical and physical characterized each other compounds, then the following administration of 50 to 75 mg/kg of PLCs did not affect the parameters of clinical chemistry. Histopathology analysis of the liver and kidney revealed normal subcellular levels in the experimental group, with the nonlethal dose at 0.9 g/kg BW.